BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23768441)

  • 1. Clinical- and cost-ineffectiveness of targeted methicillin-resistant Staphylococcus aureus screening of high-risk patients admitted to a low-prevalence teaching hospital.
    Cunha BA; Schoch P; Abruzzo ED
    Am J Infect Control; 2013 Nov; 41(11):1137-8. PubMed ID: 23768441
    [No Abstract]   [Full Text] [Related]  

  • 2. What should we do NOW? Review of a large NHS Trust's meticillin-resistant Staphylococcus aureus screening.
    Smith SJ; Manuel R; Cummins M
    J Hosp Infect; 2016 Aug; 93(4):390-1. PubMed ID: 27267618
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of screening risk and nonrisk patients for methicillin-resistant Staphylococcus aureus on admission in an acute care hospital.
    Creamer E; Galvin S; Dolan A; Sherlock O; Dimitrov BD; Fitzgerald-Hughes D; Thomas T; Walsh J; Moore J; Smyth EG; Shore AC; Sullivan D; Kinnevey P; O'Lorcain P; Cunney R; Coleman DC; Humphreys H
    Am J Infect Control; 2012 Jun; 40(5):411-5. PubMed ID: 21962934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced MRSA screening.
    Gransden W
    J Hosp Infect; 2010 Jan; 74(1):88-9. PubMed ID: 19932525
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and cost ineffectiveness of preoperative screening for methicillin-resistant Staphylococcus aureus and intranasal mupirocin in preventing methicillin-resistant S aureus infections in cardiothoracic surgery.
    Cunha BA; Thekkel V; Schoch P; Cosgrove L
    Am J Infect Control; 2011 Apr; 39(3):243-6. PubMed ID: 21145622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cost/benefit calculations of meticillin-resistant Staphylococcus aureus screening methods and their practical importance].
    Knausz M; Kaproncai G; Rozgonyi F
    Orv Hetil; 2010 May; 151(22):893-8. PubMed ID: 20478810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on screening and clinical diagnosis of meticillin-resistant Staphylococcus aureus (MRSA).
    Harbarth S; Hawkey PM; Tenover F; Stefani S; Pantosti A; Struelens MJ
    Int J Antimicrob Agents; 2011 Feb; 37(2):110-7. PubMed ID: 21163628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of targeted versus universal admission screening for meticillin-resistant Staphylococcus aureus carriage in a London hospital.
    Otter JA; Tosas-Auguet O; Herdman MT; Williams B; Tucker D; Edgeworth JD; French GL
    J Hosp Infect; 2014 Jul; 87(3):171-4. PubMed ID: 24928784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of national mandatory screening of all admissions to English National Health Service hospitals for meticillin-resistant Staphylococcus aureus: a mathematical modelling study.
    Robotham JV; Deeny SR; Fuller C; Hopkins S; Cookson B; Stone S
    Lancet Infect Dis; 2016 Mar; 16(3):348-56. PubMed ID: 26616206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local factors affecting cost/benefit of methicillin-resistant Staphylococcus aureus screening, a study from a low-income country.
    Boroumand MA; Anvari MS; Pourgholi L; Shoar S; Naderan M; Amelimojarad E; Goodarzynejad H
    Am J Infect Control; 2011 Oct; 39(8):703-705. PubMed ID: 21784560
    [No Abstract]   [Full Text] [Related]  

  • 11. Universal screening for meticillin-resistant Staphylococcus aureus: interim results from the NHS Scotland pathfinder project.
    Reilly JS; Stewart S; Christie P; Allardice G; Smith A; Masterton R; Gould IM; Williams C
    J Hosp Infect; 2010 Jan; 74(1):35-41. PubMed ID: 19959256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens.
    Wassenberg MW; Kluytmans JA; Bosboom RW; Buiting AG; van Elzakker EP; Melchers WJ; Thijsen SF; Troelstra A; Vandenbroucke-Grauls CM; Visser CE; Voss A; Wolffs PF; Wulf MW; van Zwet AA; de Wit GA; Bonten MJ
    Clin Microbiol Infect; 2011 Nov; 17(11):1704-10. PubMed ID: 21595786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal rapid screening for methicillin-resistant Staphylococcus aureus in the intensive care units in a large community hospital.
    Kjonegaard R; Fields W; Peddecord KM
    Am J Infect Control; 2013 Jan; 41(1):45-50. PubMed ID: 22651895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection.
    Gavaldà L; Masuet C; Beltran J; Garcia M; Garcia D; Sirvent JM; Ramon JM
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1264-6. PubMed ID: 17080390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods for screening for methicillin-resistant Staphylococcus aureus carriage.
    French GL
    Clin Microbiol Infect; 2009 Dec; 15 Suppl 7():10-6. PubMed ID: 19951329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of a three-year meticillin-resistant Staphylococcus aureus screening programme.
    Collins J; Raza M; Ford M; Hall L; Brydon S; Gould FK
    J Hosp Infect; 2011 Jun; 78(2):81-5. PubMed ID: 21507518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of active surveillance screening for methicillin-resistant Staphylococcus aureus in an academic hospital setting.
    Kang J; Mandsager P; Biddle AK; Weber DJ
    Infect Control Hosp Epidemiol; 2012 May; 33(5):477-86. PubMed ID: 22476274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for methicillin-resistant Staphylococcus aureus.
    McCaughey B
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):927-8. PubMed ID: 19653825
    [No Abstract]   [Full Text] [Related]  

  • 19. Search and destroy policy for methicillin-resistant Staphylococcus aureus: cost-benefit analysis.
    Simoens S; Ophals E; Schuermans A
    J Adv Nurs; 2009 Sep; 65(9):1853-9. PubMed ID: 19694848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects.
    Wassenberg MW; Kluytmans JA; Box AT; Bosboom RW; Buiting AG; van Elzakker EP; Melchers WJ; van Rijen MM; Thijsen SF; Troelstra A; Vandenbroucke-Grauls CM; Visser CE; Voss A; Wolffs PF; Wulf MW; van Zwet AA; de Wit GA; Bonten MJ
    Clin Microbiol Infect; 2010 Dec; 16(12):1754-61. PubMed ID: 20219077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.